뉴스벤징가
Celldex Treatment Fails To Relieve Chronic Itch, Abandons Prurigo Nodularis Study
· 발표
기사 요약
Celldex has discontinued its Phase 2 trial of barzolvolimab for prurigo nodularis after failing to meet primary and secondary endpoints.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…